Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 463-469

  Wu, Xiao Jiang ^a   Yuan, Peng ^a   Li, Zi Yu ^a   Bu, Zhao De ^a   Zhang, Lian Hai ^a   Wu, Ai Wen ^a   Zong, Xiang Long ^a   Li, Shuang Xi ^a   Shan, Fei ^a   Ji, Xin ^a   Ren, Hui ^a   Ji, Jia Fu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Cytoreductive surgery; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Ovarian metastasis; Peritoneal dissemination

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CYTOREDUCTIVE SURGERY; FEMALE; GASTRECTOMY; HUMAN; HYPERTHERMIC THERAPY; IATROGENIC DISEASE; KIDNEY FAILURE; LIVER DYSFUNCTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS RESECTION; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVARY METASTASIS; PATIENT SAFETY; PERITONEAL CANCER INDEX; PERITONEUM METASTASIS; PREDICTION; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STOMACH CANCER; STOMACH CARCINOMA; SURVIVAL TIME;

EID: 84872824056     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0571-4     Document Type: Article

References (30)

1. WQ Chen SW Zhang XN Zou, et al. 2011 Cancer incidence and mortality in China, 2006 Chin J Cancer Res 23 1 3 9 10.1007/s11670-011-0003-9 1:CAS:528:DC%2BC3MXht1WntbrI
2. HK Kim DS Heo YJ Bang NK Kim 2001 Prognostic factors of Krukenberg's tumor Gynecol Oncol 82 1 105 109 11426970 10.1006/gyno.2001.6210 1:STN:280:DC%2BD3Mzms1Kjtg%3D%3D
3. T Kiyokawa RH Young RE Scully 2006 Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations Am J Surg Pathol 30 3 277 299 16538048
4. N Deslauriers H Olney R Younan 2011 Splenectomy revisited in 2011: impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Gastrointest Oncol 2 2 61 63 22811831
5. JH Cheong WJ Hyung J Chen J Kim SH Choi SH Noh 2004 Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer Gynecol Oncol 94 2 477 482 15297191 10.1016/j.ygyno.2004.05.007
6. R Jiang J Tang X Cheng RY Zang 2009 Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors Eur J Surg Oncol 35 1 92 97 18632244 10.1016/j.ejso.2008.05.006 1:STN:280: DC%2BD1M%2FgtVyhtA%3D%3D
7. SY Jun JK Park 2011 Metachronous ovarian metastases following resection of the primary gastric cancer J Gastric Cancer 11 1 31 37 22076199 10.5230/jgc.2011.11.1.31
8. JH Yook ST Oh BS Kim 2007 Clinical prognostic factors for ovarian metastasis in women with gastric cancer Hepatogastroenterology 54 75 955 959 17591102
9. NK Kim HK Kim BJ Park MS Kim YI Kim DS Heo, et al. 1999 Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma Cancer 85 7 1490 1499 10193938 10.1002/(SICI)1097-0142(19990401)85:7<1490::AID- CNCR9>3.0.CO;2-G 1:STN:280:DyaK1M3gvVarsw%3D%3D
10. TP Lu MH Tsai CK Hsiao LC Lai EY Chuang 2012 Expression and functions of semaphorins in cancer Transl Cancer Res 1 2 74 87
11. F Krukenberg 1896 Uber das fibrosarcoma ovarii mucocellulase (carcinomatoses) Arch Gynecol Obstet 50 287 321
12. Serov SF, Scully RE, Sobin LH. International histological classification of tumors. No 9. Histological Typing of Ovarian Tumors. Geneva: WHO; 1973. p. 17-54.
13. N Yada-Hashimoto T Yamamoto S Kamiura H Seino H Ohira K Sawai, et al. 2003 Metastatic ovarian tumors: a review of 64 cases Gynecol Oncol 89 2 314 317 12713997 10.1016/S0090-8258(03)00075-1
14. O Kobayashi Y Sugiyama H Cho A Tsuburaya M Sairenji H Motohashi, et al. 2003 Clinical and pathological study of gastric cancer with ovarian metastasis Int J Clin Oncol 8 2 67 71 12720097 10.1007/s101470300012
15. O Glehen F Mohamed FN Gilly 2004 Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia Lancet Oncol 5 4 219 228 15050953 10.1016/S1470-2045(04)01425- 1
16. PH Sugarbaker OA Stuart L Bijelic 2012 Intraperitoneal gemcitabine chemotherapy as an adjuvant treatment for patients with resected pancreatic cancer: phase II and pharmacologic studies Transl Gastrointest Cancer 1 2 161 168
17. TD Yan D Black PH Sugarbaker J Zhu Y Yonemura G Petrou, et al. 2007 A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer Ann Surg Oncol 14 10 2702 2713 17653801 10.1245/s10434-007-9487-4
18. S Fujimoto RD Shrestha M Kokubun M Ohta M Takahashi K Kobayashi, et al. 1988 Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding Ann Surg 208 1 36 41 3133994 10.1097/00000658-198807000-00005 1:STN:280:DyaL1c3mvVaqtg%3D%3D
19. C Li M Yan J Chen M Xiang ZG Zhu HR Yin, et al. 2010 Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination J Surg Oncol 102 5 361 365 20872942 10.1002/jso.21628
20. XJ Yang CQ Huang T Suo LJ Mei GL Yang FL Cheng, et al. 2011 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial Ann Surg Oncol 18 6 1575 1581 21431408 10.1245/s10434-011-1631-5
21. YJ Bang YW Kim HK Yang HC Chung YK Park KH Lee, et al. 2012 Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 9813 315 321 22226517 10.1016/S0140-6736(11)61873-4 1:CAS:528:DC%2BC38XhsVagsr4%3D
22. M Bouchereau M Gervais L Sideris M Loriot S Ahern P Dubé 2011 Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: a review of two cases J Gastrointest Oncol 2 2 113 116 22811839
23. SR Park SY Kong J Rhee YI Park KW Ryu JH Lee, et al. 2011 Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results Ann Oncol 22 4 890 896 20860988 10.1093/annonc/mdq435 1:STN:280:DC%2BC3Mzkt1ahsw%3D%3D
24. SE Al-Batran JT Hartmann S Probst H Schmalenberg S Hollerbach R Hofheinz, et al. 2008 Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie J Clin Oncol 26 9 1435 1442 18349393 10.1200/JCO.2007.13.9378 1:CAS:528:DC%2BD1cXkslKqsL8%3D
25. O Glehen FN Gilly C Arvieux E Cotte F Boutitie B Mansvelt, et al. 2010 Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy Ann Surg Oncol 17 9 2370 2377 20336386 10.1245/s10434-010-1039-7
26. O Glehen FN Gilly F Boutitie JM Bereder F Quenet L Sideris, et al. 2010 Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients Cancer 116 24 5608 5618 20737573 10.1002/cncr.25356
27. J Esquivel 2009 Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea Cancer J 15 3 249 254 19556912 10.1097/PPO.0b013e3181a58e74
28. N Kakushima T Kamoshida S Hirai S Hotta T Hirayama J Yamada, et al. 2003 Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor J Gastroenterol 38 12 1176 1180 14714257 10.1007/s00535-003-1227-3
29. D Elias F Blot A Otmany El S Antoun P Lasser V Boige, et al. 2001 Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy Cancer 92 1 71 76 11443611 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9 1:STN:280:DC%2BD3Mvgs12itA%3D%3D
30. P Piso P Slowik F Popp MH Dahlke G Glockzin HJ Schlitt 2009 Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis Ann Surg Oncol 16 8 2188 2194 19408049 10.1245/s10434-009-0478-5